BAG3 was recently shown to be involved in cancer-signaling networks, to mediate a selective macroautophagy pathway upon protein aggregation and to attenuate proteotoxicity in cancer cells.2, 17, 47 Therefore, BAG3 also represents an interesting target for therapy in breast cancers that might have already acquired resistance to anti-hormone therapy. This evidence concerns the gene BAG3 and breast carcinoma.